Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 102951-103000 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT04357275
The RIsk Stratification in COVID-19 Patients in the ICU Registry
N/A
Active, not recruiting
10,000 participants
Started: Mar 13, 2020 · Completed: Dec 31, 2025
5 conditions
1 sponsor
1 location
NCT05761483
Endoscopic Management of Non-anastomotic Biliary Strictures Following Liver Transplantation.
N/A
Recruiting
40 participants
Started: Mar 12, 2020 · Completed: Jan 1, 2028
5 conditions
1 sponsor
1 location
NCT04263337
NFL LONG Prospective Study
PHASE1
Enrolling by invitation
250 participants
Started: Mar 12, 2020 · Completed: Dec 31, 2025
1 condition
4 sponsors
3 locations
NCT03524352
the Prophylaxis of Recurrent Pouchitis After Fecal Microbiota Transplant in UC With Ileo-anal Anastomosis
PHASE3
Recruiting
42 participants
Started: Mar 12, 2020 · Completed: May 12, 2028
1 condition
1 sponsor
13 locations
NCT04242095
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
N/A
Recruiting
240 participants
Started: Mar 12, 2020 · Completed: Oct 1, 2026
1 condition
2 sponsors
622 locations
NCT04414280
The Impact of Hybrid Closed-loop Insulin Delivery in Type 1 Diabetes on Glycemic Control and PROMs
N/A
Active, not recruiting
1,150 participants
Started: Mar 12, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
18 locations
NCT04039347
Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3)
PHASE3
Active, not recruiting
262 participants
Started: Mar 12, 2020 · Completed: Dec 31, 2025
3 conditions
1 sponsor
37 locations
NCT04437225
Renal Metabolism of Glycolate to Oxalate
NA
Recruiting
15 participants
Started: Mar 12, 2020 · Completed: Dec 1, 2026
1 condition
1 sponsor
1 location
NCT03930498
Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma
PHASE2
Active, not recruiting
68 participants
Started: Mar 12, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04094610
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
PHASE1/PHASE2
Recruiting
75 participants
Started: Mar 12, 2020 · Completed: Sep 30, 2027
4 conditions
1 sponsor
68 locations
NCT07021846
Dose Escalated Concomitant Boost Radiotherapy for Early Breast Cancer
NA
Recruiting
132 participants
Started: Mar 12, 2020 · Completed: Mar 31, 2030
1 condition
1 sponsor
1 location
NCT04276870
Orphan Indications for CD19 Redirected Autologous T Cells
PHASE2
Recruiting
133 participants
Started: Mar 12, 2020 · Completed: Mar 10, 2037
3 conditions
2 sponsors
1 location
NCT04180072
Atezolizumab Plus Bevacizumab With HCC and HBV Infection
NA
Active, not recruiting
51 participants
Started: Mar 12, 2020 · Completed: Dec 31, 2025
1 condition
9 sponsors
7 locations
NCT04309578
A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC
PHASE2
Recruiting
28 participants
Started: Mar 12, 2020 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT04316884
Mechanisms for Organ Dysfunction in Covid-19
N/A
Recruiting
300 participants
Started: Mar 12, 2020 · Completed: Dec 31, 2026
6 conditions
1 sponsor
1 location
NCT04195256
Intranasal Dexmedetomidine Plus Ketamine for Procedural Sedation
PHASE2/PHASE3
Recruiting
400 participants
Started: Mar 11, 2020 · Completed: Dec 31, 2026
2 conditions
1 sponsor
6 locations
NCT04990076
Ultrasound Evaluation of the Myometrium Using the MUSA Terminology Comparison With Histology
N/A
Recruiting
1,500 participants
Started: Mar 11, 2020 · Completed: Mar 30, 2026
2 conditions
1 sponsor
1 location
NCT04297020
Brain Health in Breast Cancer Survivors
N/A
Recruiting
120 participants
Started: Mar 11, 2020 · Completed: Mar 15, 2027
2 conditions
2 sponsors
1 location
NCT04164264
Genetic Differences in Propofol Pharmacodynamics in Children
PHASE4
Active, not recruiting
360 participants
Started: Mar 11, 2020 · Completed: Dec 31, 2024
1 condition
2 sponsors
1 location
NCT04195945
CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients
PHASE2
Active, not recruiting
60 participants
Started: Mar 11, 2020 · Completed: Dec 31, 2027
2 conditions
2 sponsors
1 location
NCT04168866
Operative Versus Non-Operative Management for Appendicitis With Abscess or Phlegmon
NA
Recruiting
180 participants
Started: Mar 11, 2020 · Completed: Dec 31, 2029
1 condition
1 sponsor
1 location
NCT04291768
Shortened Antibiotic Treatment of 5 Days in Gram-negative Bacteremia
PHASE4
Recruiting
380 participants
Started: Mar 11, 2020 · Completed: Oct 1, 2026
2 conditions
1 sponsor
13 locations
NCT04163562
Oral Immunotherapy for Peanut Allergic Patients
PHASE1/PHASE2
Recruiting
50 participants
Started: Mar 11, 2020 · Completed: Sep 30, 2025
1 condition
1 sponsor
2 locations
NCT04060758
Open Label, Sequential-dose Study of PA5108 Latanoprost FA SR Ocular Implant for Mild-moderate Glaucoma
PHASE1
Active, not recruiting
37 participants
Started: Mar 11, 2020 · Completed: Oct 31, 2025
1 condition
1 sponsor
9 locations
NCT04987528
Pulmonary Fibrosis During Severe COVID-19 Pneumonia
N/A
Active, not recruiting
200 participants
Started: Mar 11, 2020 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT04251130
Linking Tau PET to Medial Temporal Lobe Subregions With High Resolution MRI
N/A
Active, not recruiting
150 participants
Started: Mar 11, 2020 · Completed: Jan 31, 2027
1 condition
2 sponsors
1 location
NCT04947046
Carotid Stenosis Management During COVID-19 Era - Pilot Study
N/A
Recruiting
120 participants
Started: Mar 11, 2020 · Completed: Mar 1, 2026
5 conditions
1 sponsor
1 location
NCT04307914
Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases
NA
Recruiting
216 participants
Started: Mar 10, 2020 · Completed: Jun 1, 2026
9 conditions
7 sponsors
6 locations
NCT03959904
The Impact of Abdominal Wall Closure Technique on Incidence of Incisional Hernia in Kidney Transplantation
NA
Recruiting
50 participants
Started: Mar 10, 2020 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT04296162
Oral Vinorelbine or Capecitabine Combined With Trastuzumab as Adjuvant Treatment for Patients With Lymph Node Negative, HER-2 Positive and Small Tumor Size Breast Cancer (ORCHID)
PHASE2
Active, not recruiting
178 participants
Started: Mar 10, 2020 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT04204915
The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study
NA
Recruiting
2,844 participants
Started: Mar 10, 2020 · Completed: Apr 1, 2031
1 condition
4 sponsors
110 locations
NCT04142372
Tissue Microarray of Hematological Malignancies
N/A
Active, not recruiting
5,000 participants
Started: Mar 10, 2020 · Completed: Dec 31, 2026
1 condition
5 sponsors
1 location
NCT04065971
Randomized, Placebo-controlled, Double-blind Study of 2LHERP® in Orofacial Herpes Infections.
PHASE4
Recruiting
140 participants
Started: Mar 10, 2020 · Completed: Mar 31, 2027
1 condition
1 sponsor
6 locations
NCT04622670
Yoga Therapy During Chemotherapy and Radiation Treatment for the Improvement of Physical and Emotional Well-Being in Patients With Stage IB2-IIIB Cervical Cancer
NA
Active, not recruiting
40 participants
Started: Mar 10, 2020 · Completed: Jan 31, 2027
12 conditions
2 sponsors
1 location
NCT04117672
Antisecretory Factor In Severe Traumatic Brain Injury
PHASE2
Recruiting
20 participants
Started: Mar 10, 2020 · Completed: Jun 30, 2025
1 condition
3 sponsors
1 location
NCT04481061
Engaging Adolescents in Decisions About Return of Genomic Research Results
NA
Active, not recruiting
787 participants
Started: Mar 10, 2020 · Completed: Nov 30, 2026
6 conditions
2 sponsors
2 locations
NCT03496792
The Venous Distension Reflex and Orthostatic Hypertension
NA
Recruiting
30 participants
Started: Mar 10, 2020 · Completed: May 30, 2026
1 condition
1 sponsor
1 location
NCT05074316
The Myeloid Neoplasms Biology and Outcome Project
N/A
Recruiting
1,000 participants
Started: Mar 10, 2020 · Completed: Dec 31, 2032
1 condition
1 sponsor
1 location
NCT04787705
Multicenter Validation of a Predictor Model of ACHD Patients and Cardiac Surgery
N/A
Active, not recruiting
547 participants
Started: Mar 10, 2020 · Completed: Dec 31, 2025
2 conditions
5 sponsors
1 location
NCT04154943
Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma
PHASE2
Active, not recruiting
79 participants
Started: Mar 10, 2020 · Completed: Nov 28, 2025
1 condition
2 sponsors
22 locations
NCT06920992
Cognitive Control Functions of the Human Thalamus
NA
Active, not recruiting
184 participants
Started: Mar 10, 2020 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT04307485
A Study of Low Dose vs Standard Ticagrelor on Platelet Function After Intervention for Acute Coronary Syndrome in Senior Patients
PHASE4
Recruiting
40 participants
Started: Mar 10, 2020 · Completed: Jul 31, 2024
1 condition
1 sponsor
1 location
NCT04244227
Pilot Research on Opioid Use Disorder
NA
Active, not recruiting
10 participants
Started: Mar 10, 2020 · Completed: Feb 15, 2022
1 condition
3 sponsors
1 location
NCT04294368
Targeted Fortification of Donor Breast Milk in Preterm Infants
NA
Recruiting
50 participants
Started: Mar 9, 2020 · Completed: Mar 31, 2026
5 conditions
1 sponsor
1 location
NCT03803332
A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel
NA
Recruiting
208 participants
Started: Mar 9, 2020 · Completed: Sep 30, 2026
1 condition
2 sponsors
1 location
NCT04120688
3D Autotransplantation of Teeth
NA
Recruiting
120 participants
Started: Mar 9, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03847649
A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immune Related Toxicity - Substudy B: For Continued Treatment (+/- Tremelimumab) of Patients Previously Enrolled to Completed CCTG Studies
PHASE2
Recruiting
60 participants
Started: Mar 9, 2020 · Completed: Apr 30, 2031
1 condition
2 sponsors
12 locations
NCT04210687
Trapeziectomy vs. Trapeziometacarpal Limited Excision for Thumb Base Osteoarthritis
NA
Active, not recruiting
90 participants
Started: Mar 9, 2020 · Completed: May 30, 2028
1 condition
1 sponsor
1 location
NCT04228419
TSA vs RSA in Glenohumeral Osteoarthritis
NA
Recruiting
108 participants
Started: Mar 9, 2020 · Completed: Dec 31, 2032
1 condition
1 sponsor
4 locations
NCT04227028
Brigatinib and Bevacizumab for the Treatment of ALK-Rearranged Locally Advanced, Metastatic, or Recurrent NSCLC
PHASE1
Active, not recruiting
5 participants
Started: Mar 9, 2020 · Completed: Apr 21, 2026
10 conditions
2 sponsors
6 locations
Previous
1
More pages
2057
2058
2059
2060
2061
2062
2063
More pages
2369
Next